News of Rejected $120/Share Bid from Amgen Moves Onyx Shares to New Highs; Leerink Says Deal Could Push Amgen to 'Critical Mass'

Shares of Onyx Pharma (NASDAQ: ONXX ) are up more than 50 percent Monday morning following the announcement of a receipt and rejection of a $120 per share bid from Amgen (NASDAQ: AMGN ). Howard Liang, analyst at Leerink Swann, sees Onyx as an attractive target -- among a